Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer

The aim of this study was to investigate the value of serum macrophage inhibitory factor‐1 (MIC‐1) level in patients with non–small cell lung cancer (NSCLC). Serum samples from 296 patients with NSCLC and 240 healthy controls were collected. The levels of serum MIC‐1 were determined by ELISA. The se...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chunhua, Li, Li, Wang, Wei, Zhang, Qian, Zhang, Xiuwei, Yang, Rusong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957168/
https://www.ncbi.nlm.nih.gov/pubmed/33605059
http://dx.doi.org/10.1111/jcmm.16360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957168/
https://www.ncbi.nlm.nih.gov/pubmed/33605059
http://dx.doi.org/10.1111/jcmm.16360

Ejemplares similares